文献速递老年慢病共病管理老年综合评估

癌症与心血管代谢疾病组合对老年人死亡负担的联合影响

The Combined Effect of Cancer and Cardiometabolic Conditions on the Mortality Burden in Older Adults.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2019-01-01

该研究纳入四个国际队列共22,692名65岁及以上老年人,随访平均10年(8,596例死亡),分析癌症、心肌梗死、卒中和糖尿病不同组合与全因死亡率的关系。结果显示,疾病组合对死亡率加速的影响因组合不同而异,心肌梗死合并糖尿病的率推进期达10.9年,高于癌症合并糖尿病的6.4年。

要点

  • 糖尿病单病种使死亡率推进5.26年,但任何单病种影响均小于疾病组合。
  • 心肌梗死合并糖尿病率推进期为10.9年,显著高于癌症合并糖尿病的6.4年。
  • 仅用疾病计数难以指导复杂老年共病患者的个体化管理。

核心结论

  • 癌症与心血管代谢疾病的特定组合以不同方式加速老年人死亡率。
  • 疾病组合对死亡率的影响大于任何单一疾病,且相同疾病数量的不同组合影响差异显著。

研究设计与样本

  • 基于四个国际队列的纵向研究,纳入22,692名65岁及以上参与者,平均随访10年,共8,596例死亡。
  • 数据跨队列 harmonize 后,按基线癌症、心肌梗死、卒中和糖尿病创建互斥的疾病组合分组。
  • 采用 Cox 比例风险模型估计年龄和性别调整的风险比及率推进期(RAP,年)。

主要发现

  • 基线时23.6%(n=5,116)参与者报告一种疾病,4.2%(n=955)报告两种及以上疾病。
  • 率推进期随每增加一种疾病而增加。
  • 糖尿病使死亡率推进年数最多,为5.26年(95%CI 4.53-6.00)。
  • 心肌梗死合并糖尿病的率推进期为10.9年(95%CI 9.4-12.6),癌症合并糖尿病为6.4年(95%CI 4.3-8.5)。

关键数值与推荐

  • 糖尿病单病种率推进期5.26年(95%CI 4.53-6.00)。
  • 心肌梗死合并糖尿病率推进期10.9年(95%CI 9.4-12.6)。
  • 癌症合并糖尿病率推进期6.4年(95%CI 4.3-8.5)。

临床怎么用

  • 老年医学科评估共病时,应关注疾病组合的具体类型而非仅计数,以识别死亡率加速风险更高的患者。
  • 对心肌梗死合并糖尿病等特定组合的老年患者,可能需要更积极的综合管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The number of older people living with cancer and cardiometabolic conditions is increasing, but little is known about how specific combinations of these conditions impact mortality. METHODS: A total of 22,692 participants aged 65 years and older from four international cohorts were followed-up for mortality for an average of 10 years (8,596 deaths). Data were harmonized across cohorts and mutually exclusive groups of disease combinations were created for cancer, myocardial infarction (MI), stroke, and diabetes at baseline. Cox proportional hazards models for all-cause mortality were used to estimate the age- and sex-adjusted hazard ratio and rate advancement period (RAP) (in years). RESULTS: At baseline, 23.6% (n = 5,116) of participants reported having one condition and 4.2% (n = 955) had two or more conditions. Data from all studies combined showed that the RAP increased with each additional condition. Diabetes advanced the rate of dying by the most years (5.26 years; 95% confidence interval [CI], 4.53-6.00), but the effect of any single condition was smaller than the effect of disease combinations. Some combinations had a significantly greater impact on the period by which the rate of death was advanced than others with the same number of conditions, for example, 10.9 years (95% CI, 9.4-12.6) for MI and diabetes versus 6.4 years (95% CI, 4.3-8.5) for cancer and diabetes. CONCLUSIONS: Combinations of cancer and cardiometabolic conditions accelerate mortality rates in older adults differently. Although most studies investigating mortality associated with multimorbidity used disease counts, these provide little guidance for managing complex patients as they age.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Raina P, Gilsing A, Freisling H, et al. The Combined Effect of Cancer and Cardiometabolic Conditions on the Mortality Burden in Older Adults. J Gerontol A Biol Sci Med Sci. 2019. PMID: 29562321. doi:10.1093/gerona/gly053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。